{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:54:30Z","timestamp":1765727670182},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1007\/s11864-004-0020-8","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T08:46:16Z","timestamp":1183020376000},"page":"289-303","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Treatment of T-cell non-hodgkin\u2019 lymphoma"],"prefix":"10.1007","volume":"5","author":[{"given":"Andrew M.","family":"Evens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald B.","family":"Gartenhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"20_CR1","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","volume":"89","author":"A Melnyk","year":"1997","unstructured":"Melnyk A, Rodriguez A, Pugh WC, Cabannillas F: Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma?\n                           Blood 1997, 89:4514\u20134520. A large report on the importance of T-cell phenotype in NHL with associated prognostic variables and impact on survival.","journal-title":"Blood"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"JO Armitage","year":"1998","unstructured":"Armitage JO, Weisenburger DD: New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project?\n                           J Clin Oncol 1998, 16:2780\u20132795.","journal-title":"J Clin Oncol"},{"key":"20_CR3","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, et al.: Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lym-phomes de l\u2019Adulte (GELA)?\n                           Blood, 1998. 92:76\u201382. A large report on the importance of T-cell phenotype in NHL with associated prognostic variables and impact on survival.","journal-title":"Blood"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Weisenburger DD, Anderson JR, et al.: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project?\n                           Ann Oncol 2002, 13:140\u2013149. A multi-institution review on classification, clinical features, and outcomes from a large T-cell NHL database.","journal-title":"Ann Oncol"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, et al.: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clini-cal Advisory Committee meeting-Airlie House, Virginia, November 1997?\n                           J Clin Oncol 1999, 17:3835\u20133849.","journal-title":"J Clin Oncol"},{"key":"20_CR6","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2000.18.15.2908","volume":"18","author":"RS Siegel","year":"2000","unstructured":"Siegel RS, Pandolfino T, Guitart J, et al.: Primary cutaneous T-cell lymphoma: review and current con-cepts?\n                           J Clin Oncol 2000, 18:2908\u20132925.","journal-title":"J Clin Oncol"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00277-002-0450-y","volume":"81","author":"J Pellatt","year":"2002","unstructured":"Pellatt J, Sweetenham J, Pickering RM, et al.: A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin\u2019s lymphoma?\n                           Ann Hematol 2002, 81: 267\u2013272.","journal-title":"Ann Hematol"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1182\/blood.V97.11.3612","volume":"97","author":"T Itoyama","year":"2001","unstructured":"Itoyama T, Chaganti RS, Yamada Y, et al.: Cytogenetic analysis and clinical significance in adult T-cell leukemia\/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki?\n                           Blood 2001, 97:3612\u20133620.","journal-title":"Blood"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199509059657","volume":"19","author":"I Anagnostopoulos","year":"1995","unstructured":"Anagnostopoulos I, Hummel M, Stein H: Frequent presence of latent Epstein-Barr virus infection in peripheral T-cell lymphomas: a review?\n                           Leuk Lymphoma 1995, 19:1\u201312.","journal-title":"Leuk Lymphoma"},{"key":"20_CR10","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1182\/blood.V87.9.3903.bloodjournal8793903","volume":"87","author":"M Luppi","year":"1996","unstructured":"Luppi M, Barozzi P, Maiorana A, et al.: Human herpes-virus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopa-thy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity?\n                           Blood 1996, 87:3903\u20133909.","journal-title":"Blood"},{"key":"20_CR11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood.V87.3.1045.bloodjournal8731045","volume":"87","author":"F d\u2019Amore","year":"1996","unstructured":"d\u2019Amore F, Johansen P, Houmand A, et al.: Epstein-Barr virus genome in non-Hodgkin\u2019s lymphomas occur-ring in immunocompetent patients: highest preva-lence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO?\n                           Blood 1996, 87:1045\u20131055.","journal-title":"Blood"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/smim.1999.0180","volume":"11","author":"AC Hayday","year":"1999","unstructured":"Hayday AC, Barber DF, Douglas N, Hoffman ES: Signals involved in gamma\/delta T cell versus alpha\/beta T cell lineage commitment?\n                           Semin Immunol 1999, 11: 239\u2013249.","journal-title":"Semin Immunol"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"D156","DOI":"10.2741\/922","volume":"8","author":"AM Evens","year":"2003","unstructured":"Evens AM, Gartenhaus RB: Molecular etiology of mature T-cell non-Hodgkin\u2019s lymphomas?\n                           Front Biosci 2003, 8:D156-D175.","journal-title":"Front Biosci"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/10428190290016926","volume":"43","author":"M Reiser","year":"2002","unstructured":"Reiser M, Josting A, Soltani M, et al.: T-cell non-Hodgkin\u2019s lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors?\n                           Leuk Lymphoma 2002, 43:805\u2013811. A recent report describing clinical factors, prognostic variables, and treatment outcomes for T-cell NHL.","journal-title":"Leuk Lymphoma"},{"key":"20_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10428199609045720","volume":"24","author":"T Karakas","year":"1996","unstructured":"Karakas T, Bergmann L, Stutte HJ, et al.: Peripheral T-cell lymphomas respond well to vincristine, adriamy-cin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas?\n                           Leuk Lymphoma 1996, 24:121\u2013129.","journal-title":"Leuk Lymphoma"},{"key":"20_CR16","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","volume":"15","author":"SM Ansell","year":"1997","unstructured":"Ansell SM, Habermann TM, Kurtin PJ, et al.: Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma?\n                           J Clin Oncol 1997, 15:2296\u20132301.","journal-title":"J Clin Oncol"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","volume":"53","author":"A Jemal","year":"2003","unstructured":"Jemal A, Murray T, Samuels A, et al.: Cancer statistics, 2003?\n                           CA Cancer J Clin 2003, 53:5\u201326.","journal-title":"CA Cancer J Clin"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJM199211053271903","volume":"327","author":"LI Gordon","year":"1992","unstructured":"Gordon LI, Harrington D, Andersen J, et al.: Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin\u2019s lymphoma?\n                           N Engl J Med 1992, 327:1342\u20131349.","journal-title":"N Engl J Med"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RI Fisher","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, et al.: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma?\n                           N Engl J Med 1993, 328:1002\u20131006.","journal-title":"N Engl J Med"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1749-6632.2001.tb03724.x","volume":"941","author":"R Kurzrock","year":"2001","unstructured":"Kurzrock R: Therapy of T-cell lymphomas with pentostatin?\n                           Ann N Y Acad Sci 2001, 941:200\u2013205.","journal-title":"Ann N Y Acad Sci"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1046\/j.1365-2141.2002.03537_3.x","volume":"117","author":"E Iannitto","year":"2002","unstructured":"Iannitto E, Barbera V, Quintini G, et al.: Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin?\n                           Br J Haematol 2002, 117:995\u2013996.","journal-title":"Br J Haematol"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1365-2141.2001.02743.x","volume":"113","author":"S Sallah","year":"2001","unstructured":"Sallah S, Wan JY, Nguyen NP: Treatment of refractory T-cell malignancies using gemcitabine?\n                           Br J Haematol 2001, 113: 185\u2013187.","journal-title":"Br J Haematol"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1023\/A:1008409601731","volume":"9","author":"PL Zinzani","year":"1998","unstructured":"Zinzani PL, Magagnoli M, Bendandi M, et al.: Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients?\n                           Ann Oncol 1998, 9:1351\u20131353.","journal-title":"Ann Oncol"},{"key":"20_CR24","first-page":"399","volume":"91","author":"CF LeMaistre","year":"1998","unstructured":"LeMaistre CF, Saleh MN, Kuzel TM, et al.: Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2?\n                           Blood 1998, 91: 399\u2013405.","journal-title":"Blood"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/10428190210183","volume":"43","author":"R Talpur","year":"2002","unstructured":"Talpur R, Apisarnthanarax N, Ward S, Duvic M: Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (ONTAK)?\n                           Leuk Lymphoma 2002, 43:121\u2013126.","journal-title":"Leuk Lymphoma"},{"key":"20_CR26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1080\/1042819022386806","volume":"43","author":"CL Huang","year":"2002","unstructured":"Huang CL, Lin ZZ, Su IJ, et al.: Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma?\n                           Leuk Lymphoma 2002, 43:1415\u20131420.","journal-title":"Leuk Lymphoma"},{"key":"20_CR27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","volume":"6","author":"W Siegert","year":"1995","unstructured":"Siegert W, Nerl C, Agthe A, et al.: Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group?\n                           Ann Oncol 1995, 6:659\u2013664.","journal-title":"Ann Oncol"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000040811","volume":"99","author":"S Sallah","year":"1998","unstructured":"Sallah S, Gagnon GA: Angioimmunoblastic lymph-adenopathy with dysproteinemia: emphasis on patho-genesis and treatment?\n                           Acta Haematol 1998, 99:57\u201364.","journal-title":"Acta Haematol"},{"key":"20_CR29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-117-5-364","volume":"117","author":"W Siegert","year":"1992","unstructured":"Siegert W, Agthe A, Griesser H, et al.: Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM\/IMVP-16 regimen: a multicenter study. Kiel Lymphoma Study Group?\n                           Ann Intern Med 1992, 117: 364\u2013370.","journal-title":"Ann Intern Med"},{"key":"20_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.thj.6200136","volume":"2","author":"G Quintini","year":"2001","unstructured":"Quintini G, Iannitto E, Barbera V, et al.: Response to low-dose oral methotrexate and prednisone in two patients with angio-immunoblastic lymphadenopathy-type T-cell lymphoma?\n                           Hematol J 2001, 2:393\u2013395.","journal-title":"Hematol J"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000046545","volume":"105","author":"C Tsatalas","year":"2001","unstructured":"Tsatalas C, Margaritis D, Kaloutsi V, et al.: Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine?\n                           Acta Haematol 2001, 105: 106\u2013108.","journal-title":"Acta Haematol"},{"key":"20_CR32","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","volume":"96","author":"H Stein","year":"2000","unstructured":"Stein H, Foss HD, Durkop H, et al.: CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features?\n                           Blood 2000, 96:3681\u20133695. An excellent overall review of anaplastic lymphoma.","journal-title":"Blood"},{"key":"20_CR33","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood.V90.9.3727","volume":"90","author":"H Tilly","year":"1997","unstructured":"Tilly H, Gaulard P, Lepage E, et al.: Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome?\n                           Blood 1997, 90:3727\u20133734.","journal-title":"Blood"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1200\/JCO.2002.12.033","volume":"20","author":"JL Kutok","year":"2002","unstructured":"Kutok JL, Aster JC: Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma?\n                           J Clin Oncol 2002, 20:3691\u20133702.","journal-title":"J Clin Oncol"},{"key":"20_CR35","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/blood.V93.11.3913","volume":"93","author":"RD Gascoyne","year":"1999","unstructured":"Gascoyne RD, Aoun P, Wu D, et al.: Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma?\n                           Blood 1999, 93:3913\u20133921.","journal-title":"Blood"},{"key":"20_CR36","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood.V96.6.2172","volume":"96","author":"R Suzuki","year":"2000","unstructured":"Suzuki R, Kagami Y, Takeuchi K, et al.: Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype?\n                           Blood 2000, 96:2993\u20133000.","journal-title":"Blood"},{"key":"20_CR37","first-page":"2697","volume":"93","author":"B Falini","year":"1999","unstructured":"Falini B, Pileri S, Zinzani PL, et al.: ALK+ lymphoma: clinico-pathological findings and outcome?\n                           Blood 1999, 93:2697\u20132706.","journal-title":"Blood"},{"key":"20_CR38","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood.V97.12.3699","volume":"97","author":"K Seidemann","year":"2001","unstructured":"Seidemann K, Tiemann M, Schrappe M, et al.: Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90?\n                           Blood 2001, 97:3699\u20133706.","journal-title":"Blood"},{"key":"20_CR39","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","volume":"95","author":"MW Bekkenk","year":"2000","unstructured":"Bekkenk MW, Geelen FA, van Voorst Vader PC, et al.: Primary and secondary cutaneous CD30(+) lympho-proliferative disorders: a report from the Dutch Cuta-neous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment?\n                           Blood 2000, 95:3653\u20133661.","journal-title":"Blood"},{"key":"20_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0046-8177(98)90122-8","volume":"29","author":"S Kumar","year":"1998","unstructured":"Kumar S, Krenacs L, Medeiros J, et al.: Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes?\n                           Hum Pathol 1998, 29:397\u2013403.","journal-title":"Hum Pathol"},{"key":"20_CR41","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/00000478-199807000-00010","volume":"22","author":"KE Salhany","year":"1998","unstructured":"Salhany KE, Macon WR, Choi JK, et al.: Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha\/ beta and gamma\/delta subtypes?\n                           Am J Surg Pathol 1998, 22:881\u2013893.","journal-title":"Am J Surg Pathol"},{"key":"20_CR42","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/archderm.136.7.889","volume":"136","author":"AV Marzano","year":"2000","unstructured":"Marzano AV, Berti E, Paulli M, Caputo R: Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma: report of 7 cases?\n                           Arch Dermatol 2000, 136:889\u2013896.","journal-title":"Arch Dermatol"},{"key":"20_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1046\/j.1365-2133.2000.03671.x","volume":"143","author":"WM Ng","year":"2000","unstructured":"WY, Ng WM, Choy C, Kwong YL: Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone?\n                           Br J Dermatol 2000, 143:408\u201310.","journal-title":"Br J Dermatol"},{"key":"20_CR44","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","volume":"88","author":"CB Cooke","year":"1996","unstructured":"Cooke CB, Krenacs L, Stetler-Stevenson M, et al.: Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin?\n                           Blood 1996, 88:4265\u2013274.","journal-title":"Blood"},{"key":"20_CR45","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/sj.leu.2401784","volume":"14","author":"E Weidmann","year":"2000","unstructured":"Weidmann E: Hepatosplenic T cell lymphoma: a review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990?\n                           Leukemia 2000, 14:991\u201397.","journal-title":"Leukemia"},{"key":"20_CR46","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1182\/blood.V88.9.3626.bloodjournal8893626","volume":"88","author":"MN Hanson","year":"1996","unstructured":"Hanson MN, Morrison VA, Peterson BA, et al.: Post-transplant T-cell lymphoproliferative disorders: an aggressive, late complication of solid-organ transplantation?\n                           Blood 1996, 88:3626\u2013633.","journal-title":"Blood"},{"key":"20_CR47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","volume":"16","author":"MM Cheung","year":"1998","unstructured":"Cheung MM, Chan JK, Lau WH, et al.: Primary non-Hodgkin\u2019s lymphoma of the nose and nasopharynx: clin-ical features, tumor immunophenotype, and treatment outcome in 113 patients?\n                           J Clin Oncol 1998, 16:70\u20137. A large collection of patients with nasal T-cell NHL with description of clinical and treatment outcome.","journal-title":"J Clin Oncol"},{"key":"20_CR48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","volume":"18","author":"GE Kim","year":"2000","unstructured":"Kim GE, Cho JH, Yang WI, et al.: Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment?\n                           J Clin Oncol 2000, 18:54\u20133.","journal-title":"J Clin Oncol"},{"key":"20_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W","volume":"83","author":"YX Li","year":"1998","unstructured":"Li YX, Coucke PA, Li JY, et al.: Primary non-Hodgkin\u2019s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy?\n                           Cancer 1998, 83:449\u201356.","journal-title":"Cancer"},{"key":"20_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","volume":"61","author":"GE Kim","year":"2001","unstructured":"Kim GE, Lee SW, Chang SK, et al.: Combined chemo-therapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck?\n                           Radiother Oncol 2001, 61: 261\u201369.","journal-title":"Radiother Oncol"},{"key":"20_CR51","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","volume":"18","author":"J Gale","year":"2000","unstructured":"Gale J, Simmonds PD, Mead GM, et al.: Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center?\n                           J Clin Oncol 2000, 18:795\u201303. The largest available collection of patients with intestinal T-cell NHL with emphasis on clinical features and treatment.","journal-title":"J Clin Oncol"},{"key":"20_CR52","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/blood.V89.2.644","volume":"89","author":"L Quintanilla-Martinez","year":"1997","unstructured":"Quintanilla-Martinez L, Lome-Maldonado C, Ott G, et al.: Primary non-Hodgkin\u2019s lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases?\n                           Blood 1997, 89:644\u201351.","journal-title":"Blood"},{"key":"20_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/gut.52.3.347","volume":"52","author":"M Hoffmann","year":"2003","unstructured":"Hoffmann M, Vogelsang H, Kletter K, et al.: 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma?\n                           Gut 2003, 52:347\u201351.","journal-title":"Gut"},{"key":"20_CR54","first-page":"2849","volume":"96","author":"ME El-Sabban","year":"2000","unstructured":"El-Sabban ME, Nasr R, Dbaibo G, et al.: Arsenic-inter-feron-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation?\n                           Blood 2000, 96:2849\u2013855.","journal-title":"Blood"},{"key":"20_CR55","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V93.1.278","volume":"93","author":"A Bazarbachi","year":"1999","unstructured":"Bazarbachi A, El-Sabban ME, Nasr R, et al.: Arsenic triox-ide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells?\n                           Blood 1999, 93:278\u201383.","journal-title":"Blood"},{"key":"20_CR56","first-page":"2540","volume":"5","author":"J Dierov","year":"1999","unstructured":"Dierov J, Sawaya BE, Prosniak M, Gartenhaus RB: Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cells?\n                           Clin Cancer Res 1999, 5:2540\u2013547.","journal-title":"Clin Cancer Res"},{"key":"20_CR57","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","volume":"113","author":"E Matutes","year":"2001","unstructured":"Matutes E, Taylor GP, Cavenagh J, et al.: Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol 2001, 113: 779\u201384.","journal-title":"Br J Haematol"},{"key":"20_CR58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.thj.6200195","volume":"3","author":"O Hermine","year":"2002","unstructured":"Hermine O, Allard I, Levy V, et al.: A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma?\n                           Hematol J 2002, 3:276\u201382.","journal-title":"Hematol J"},{"key":"20_CR59","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1080\/1042819021000039983","volume":"43","author":"C Besson","year":"2002","unstructured":"Besson C, Panelatti G, Delaunay C, et al.: Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide?\n                           Leuk Lymphoma 2002, 43:2275\u2013279.","journal-title":"Leuk Lymphoma"},{"key":"20_CR60","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, et al.: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma?\n                           N Engl J Med 1995, 333:1540\u2013545.","journal-title":"N Engl J Med"},{"key":"20_CR61","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s00277-002-0556-2","volume":"81","author":"C Kahl","year":"2002","unstructured":"Kahl C, Leithauser M, Wolff D, et al.: Treatment of periph-eral T-cell lymphomas (PTCL) with high-dose chemo-therapy and autologous or allogeneic hematopoietic transplantation?\n                           Ann Hematol 2002, 81: 646\u201350.","journal-title":"Ann Hematol"},{"key":"20_CR62","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","volume":"27","author":"AK Blystad","year":"2001","unstructured":"Blystad AK, Enblad G, Kvaloy S, et al.: High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas?\n                           Bone Marrow Transplant 2001, 27:711\u201316.","journal-title":"Bone Marrow Transplant"},{"key":"20_CR63","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","volume":"19","author":"J Rodriguez","year":"2001","unstructured":"Rodriguez J, Munsell M, Yazji S, et al.: Impact of high-dose chemotherapy on peripheral T-cell lymphomas?\n                           J Clin Oncol 2001, 19:3766\u2013770.","journal-title":"J Clin Oncol"},{"key":"20_CR64","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1046\/j.1365-2141.2003.04203.x","volume":"120","author":"KW Song","year":"2003","unstructured":"Song KW, Mollee P, Keating A, Crump M: Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype?\n                           Br J Haematol 2003, 120:978\u201385.","journal-title":"Br J Haematol"},{"key":"20_CR65","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1046\/j.1365-2141.2000.02098.x","volume":"109","author":"E Deconinck","year":"2000","unstructured":"Deconinck E, Lamy T, Foussard C, et al.: Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial?\n                           Br J Haematol 2000, 109: 736\u201342.","journal-title":"Br J Haematol"},{"key":"20_CR66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/10428199909145715","volume":"35","author":"R Fanin","year":"1999","unstructured":"Fanin R, Sperotto A, Silvestri F, et al.: The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center?\n                           Leuk Lymphoma 1999, 35:159\u201369.","journal-title":"Leuk Lymphoma"},{"key":"20_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.bmt.1703796","volume":"31","author":"T Okamura","year":"2003","unstructured":"Okamura T, Kishimoto T, Inoue M, et al.: Unrelated bone marrow transplantation for Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disease?\n                           Bone Marrow Transplant 2003, 31: 105\u2013111.","journal-title":"Bone Marrow Transplant"},{"key":"20_CR68","first-page":"2345","volume":"8","author":"S Nagata","year":"2002","unstructured":"Nagata S, Onda M, Numata Y, et al.: Novel anti-CD30 recombinant immunotoxins containing disulfide-stabi-lized Fv fragments?\n                           Clin Cancer Res 2002, 8:2345\u2013355.","journal-title":"Clin Cancer Res"},{"key":"20_CR69","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.leu.2402458","volume":"16","author":"Y Hatta","year":"2002","unstructured":"Hatta Y, Koeffler HP: Role of tumor suppressor genes in the development of adult T cell leukemia\/lym-phoma (ATLL)?\n                           Leukemia 2002, 16:1069\u20131085.","journal-title":"Leukemia"},{"key":"20_CR70","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3109\/10428190109097731","volume":"42","author":"WK Hofmann","year":"2001","unstructured":"Hofmann WK, Tsukasaki K, Takeuchi N, et al.: Methylation analysis of cell cycle control genes in adult T-cell leuke-mia\/ lymphoma?\n                           Leuk Lymphoma 2001, 42:1107\u20131109.","journal-title":"Leuk Lymphoma"},{"key":"20_CR71","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","volume":"98","author":"RL Piekarz","year":"2001","unstructured":"Piekarz RL, Robey R, Sandor V, et al.: Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report?\n                           Blood 2001, 98:2865\u2013868.","journal-title":"Blood"},{"key":"20_CR72","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/gut.48.2.269","volume":"48","author":"C Bariol","year":"2001","unstructured":"Bariol C, Field A, Vickers CR, Ward R: Regression of gastric T cell lymphoma with eradication of Helicobacter pylori?\n                           Gut 2001, 48:269\u201371.","journal-title":"Gut"},{"key":"20_CR73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0014-5793(02)02914-9","volume":"522","author":"GC Fillmore","year":"2002","unstructured":"Fillmore GC, Lin Z, Bohling SD, et al.: Gene expression profiling of cell lines derived from T-cell malignancies?\n                           FEBS Lett 2002, 522:183\u201388.","journal-title":"FEBS Lett"},{"key":"20_CR74","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1182\/blood.V99.6.2100","volume":"99","author":"L Passoni","year":"2002","unstructured":"Passoni L, Scardino A, Bertazzoli C, et al.: ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes?\n                           Blood 2002, 99:2100\u2013106.","journal-title":"Blood"},{"key":"20_CR75","first-page":"1757","volume":"62","author":"SM Thirdborough","year":"2002","unstructured":"Thirdborough SM, Radcliffe JN, Friedmann PS, Stevenson FK: Vaccination with DNA encoding a single-chain TCR fusion protein induces anticlonotypic immunity and protects against T-cell lymphoma?\n                           Cancer Res 2002, 62:1757\u2013760.","journal-title":"Cancer Res"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0020-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-004-0020-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0020-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0020-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:33:54Z","timestamp":1659090834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-004-0020-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s11864-004-0020-8","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}